Dear Sir/Madam, Pursuant to Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, please find attached the attached disclosure for your reference ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Prism Medico and Pharmacy Ltd has filed a disclosure confirming that promoters and persons acting in concert (PACs) have not encumbered any shares during FY 2025-26. The confirmation was provided by Symbiosis Pharmaceuticals Private Limited on behalf of all promoters. This filing is a routine regulatory requirement under SEBI Takeover Regulations to disclose promoter pledge status. No new pledges or encumbrances were created during the year beyond previously disclosed ones.
Positive for shareholders as no additional promoter share pledging occurred, indicating promoters have not used their shares as collateral for loans. This maintains stability in the promoter shareholding structure and reduces risk of potential supply pressure in the market.